Phase I trial of poly-L-glutamate camptothecin (CT-2106) administered weekly in patients with advanced solid malignancies (Q28251524)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Phase I trial of poly-L-glutamate camptothecin (CT-2106) administered weekly in patients with advanced solid malignancies
scientific article

    Statements

    Phase I trial of poly-L-glutamate camptothecin (CT-2106) administered weekly in patients with advanced solid malignancies (English)
    0 references
    Jade Homsi
    0 references
    George R Simon
    0 references
    Chris R Garrett
    0 references
    Gregory Springett
    0 references
    Ronald De Conti
    0 references
    Alberto A Chiappori
    0 references
    Pamela N Munster
    0 references
    Michelle K Burton
    0 references
    Scott Stromatt
    0 references
    Claudia Allievi
    0 references
    Patrizia Angiuli
    0 references
    Amy Eisenfeld
    0 references
    Daniel M Sullivan
    0 references
    Adil I Daud
    0 references
    1 October 2007
    0 references
    13
    0 references
    19
    0 references
    5855-61
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit